Heterogeneity of Rotavirus Vaccine Efficacy among Infants in Developing Countries

Pediatric Infectious Disease Journal

Volumn 36, Issue 1, 2017, Pages 72-78

  Gruber, Joann F ^a,b   Hille, Darcy A ^b   Liu, G Frank ^b   Kaplan, Susan S ^b   Nelson, Micki ^b   Goveia, Michelle G ^b   Mast, T Christopher ^b  

^a University of North Carolina at Chapel Hill   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

developing countries; gastroenteritis; rotavirus; vaccine

Indexed keywords

PLACEBO; ROTAVIRUS VACCINE;

ARTICLE; BANGLADESH; BREAST FEEDING; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTROENTERITIS; GHANA; HUMAN; INFANT; INFANT CARE; KENYA; MAJOR CLINICAL STUDY; MALE; MALI; MULTICENTER STUDY; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ROTAVIRUS INFECTION; SEX DIFFERENCE; UNDERWEIGHT; VIET NAM; NEWBORN; ROTAVIRUS; ROTAVIRUS INFECTIONS; STATISTICS AND NUMERICAL DATA; VACCINATION;

BANGLADESH; DEVELOPING COUNTRIES; FEMALE; GASTROENTERITIS; GHANA; HUMANS; INFANT; INFANT, NEWBORN; MALE; MALI; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 84991511272     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001362     Document Type: Article

References (25)

1. Dennehy PH. Rotavirus vaccines: an overview. Clin Microbiol Rev. 2008;21:198-208.
2. Shaw AR. The rotavirus saga revisited. Annu Rev Med. 2013;64:165-174.
3. Rotavirus vaccines. WHO position paper-January 2013. Releve epidemiologique hebdomadaire /Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record /Health Section of the Secretariat of the League of Nations. 2013;88:49-64.
4. World Health Organization. Rotavirus April 12, 2010. 2010. Available at: http://www.who.int/immunization/topics/rotavirus/en/. Accessed July 6, 2015.
5. Meeting of the immunization Strategic Advisory Group of Experts, April 2009-conclusions and recommendations. Releve epidemiologique hebdomadaire /Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record /Health Section of the Secretariat of the League of Nations. 2009;84:220-236.
6. Country introductions of rotavirus vaccines 2016. Available at: http://sites. path.org/rotavirusvaccine/country-introduction-maps-and-spreadsheet/. Accessed May 20, 2016.
7. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362:299-305.
8. Richardson V, Parashar U, Patel M. Childhood diarrhea deaths after rotavirus vaccination in Mexico. N Engl J Med. 2011;365:772-773.
9. Paternina-Caicedo A, Parashar UD, Alvis-Guzmán N, et al. Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries. Vaccine. 2015;33:3923-3928.
10. Payne DC, Staat MA, Edwards KM, et al; New Vaccine Surveillance Network (NVSN). Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis. 2011;53:245-253.
11. Vesikari T, Matson DO, Dennehy P, et al; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33.
12. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:606-614.
13. Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:615-623.
14. John TJ. Antibody response of infants in tropics to five doses of oral polio vaccine. Br Med J. 1976;1:812.
15. Suharyono, Simanjuntak C, Witham N, et al. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet. 1992;340:689-694.
16. Simanjuntak CH, Paleologo FP, Punjabi NH, et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet. 1991;338:1055-1059.
17. Feikin DR, Laserson KF, Ojwando J, et al. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya. Vaccine. 2012;30(suppl 1):A52-A60.
18. Child Growth Standards 2006. Available at: http://www.who.int/childgrowth/standards/en/. Accessed July 6, 2015.
19. Sow SO, Tapia M, Haidara FC, et al. Efficacy of the oral pentavalent rotavirus vaccine in Mali. Vaccine. 2012;30(suppl 1):A71-A78.
20. Chan J, Nirwati H, Triasih R, et al. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? Vaccine. 2011;29:1242-1247.
21. Patel M, Shane AL, Parashar UD, et al. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis. 2009;200 Suppl 1:S39-S48.
22. Morris SK, Awasthi S, Khera A, et al; Million Death Study Collaborators. Rotavirus mortality in India: estimates based on a nationally representative survey of diarrhoeal deaths. Bull World Health Organ. 2012;90:720-727.
23. Parashar UD, Nelson EA, Kang G. Diagnosis, management, and prevention of rotavirus gastroenteritis in children. BMJ. 2013;347:f7204.
24. Haque R, Snider C, Liu Y, et al. Oral polio vaccine response in breast fed infants with malnutrition and diarrhea. Vaccine. 2014;32:478-482.
25. Peduzzi P, Henderson W, Hartigan P, et al. Analysis of randomized controlled trials. Epidemiol Rev. 2002;24:26-38.